Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Ned Tijdschr Geneeskd ; 150(17): 977-9, 2006 Apr 29.
Article in Dutch | MEDLINE | ID: mdl-17225740

ABSTRACT

An 80-year-old woman with a history of familial primary generalised epilepsy presented to the outpatient clinic with complaints of dizziness, confusion, dullness and feeling of'being worthless'. It turned out that she had been using medication for some time in which the chemical nature of the pharmacologically active ingredient had been changed: methylphenobarbital 60 mg t.i.d. had been replaced by phenobarbital 60 mg t.i.d. The resultant phenobarbital concentration was much higher than the concentration to which she was accustomed. At the same dosage, phenobarbital is more active than methylphenobarbital. When one compound ofa pharmacologically active substance is replaced by a different compound, the dosage should be corrected for both the chemical structure, such as the molecular weight, and the pharmacokinetic properties such as absorption, metabolism and biological availability.


Subject(s)
Anticonvulsants/adverse effects , Anticonvulsants/metabolism , Mephobarbital/metabolism , Phenobarbital/adverse effects , Phenobarbital/metabolism , Aged, 80 and over , Biological Availability , Female , Humans , Intestinal Absorption , Mephobarbital/administration & dosage , Mephobarbital/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...